• ATRX-Deficient Glioma and RTK Inhibitor Sensitivity

  2026-08-24

  The reference study identifies ATRX deficiency as a potential determinant of response to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its strongest translational implication is that ATRX status may help interpret RTK inhibitor trials and guide studies combining these agents with temozolomide.

• Foretinib: From Kinase Maps to Translational Insight

  2026-08-24

  Foretinib (GSK1363089) is more than a potent multikinase tool: it can help translational researchers connect receptor signaling, tumor cell growth inhibition, motility, invasion, and metastasis. This thought-leadership guide presents an evidence-aware framework for interpreting response biology, designing orthogonal assays, and moving from cell models toward cancer metastasis model and ovarian cancer xenograft studies without overstating what preclinical data can prove.

• 4-PBA Workflow for ER Stress Research

  2026-08-23

  4-PBA provides a practical chemical-chaperone approach for separating endoplasmic reticulum stress from downstream ferroptosis, apoptosis, and autophagy phenotypes. This workflow translates PFOS-induced HK-2 cell injury findings into actionable treatment groups, assay choices, optimization steps, and reproducible controls.

• Tivozanib (AV-951) In Vitro Research Workflow

  2026-08-22

  Tivozanib (AV-951) combines picomolar VEGFR-2 potency with a selective profile suited to pathway validation, anti-angiogenic therapy studies, and combination screening. This workflow pairs conventional viability testing with direct cell-death measurements to distinguish cytostasis from true tumor-cell killing.

• Pazopanib (GW-786034): Assay Reliability

  2026-08-22

  This scenario-based guide explains how Pazopanib (GW-786034), SKU A3022, can support reproducible cell viability, proliferation, and cytotoxicity workflows. It connects formulation, pathway biology, genotype-aware experimental design, dose interpretation, and practical vendor selection to evidence from product information and peer-reviewed cancer research.

• Latrunculin B: Workflow for Actin Dynamics

  2026-08-21

  Latrunculin B enables short, controlled pulses of actin filament assembly inhibition for imaging, cytoskeletal organization studies, and entry-mechanism experiments. Its transient activity is especially valuable when researchers need reversible actin cytoskeleton disruption rather than a persistent phenotype.

• PHF2 Links Neuroinflammation to Memory in Alzheimer’s

  2026-08-20

  The 2025 Molecular Psychiatry study identifies the histone demethylase PHF2 as an epigenetic regulator of inflammatory gene expression in Alzheimer’s disease. By combining human datasets, iPSC-derived neurons, genomic profiling, gene manipulation, synaptic assays, and behavioral testing, the authors connect elevated PHF2 with neuroinflammation, synaptic dysfunction, and spatial memory impairment in a familial Alzheimer’s model.

• FGFR1 Controls Early Human Adipogenesis

  2026-08-20

  Widberg and colleagues showed that FGF-1 does more than stimulate human preadipocyte proliferation: it uniquely primes these cells for later adipocyte differentiation through FGFR1-dependent signaling. By combining growth-factor comparisons, pharmacological inhibition, and FGFR1 knockdown, the study established an important mechanistic link between early adipogenic events and adipose tissue expansion.

• Firefly Luciferase mRNA Workflow for LNP Assays

  2026-08-19

  Build a reproducible reporter workflow for comparing mRNA delivery, translation, stability, and cellular distribution with a capped, 5-moUTP-modified transcript. The guide connects quantitative luciferase imaging with the reference study’s lipid nanoparticle-stabilized emulsion strategy while clearly separating reporter evidence from immune-function conclusions.

• Red Blood Cell Lysis Buffer: Practical Workflows

  2026-08-19

  Build cleaner mammalian blood sample preparation workflows for flow cytometry, nucleic acid extraction, protein assays, and cell culture. This guide explains selective erythrocyte removal, practical starting conditions, assay-specific optimization, and troubleshooting for Red Blood Cell Lysis Buffer.

• Resiquimod (R-848) in Ablation Workflows

  2026-08-18

  Resiquimod (R-848) connects TLR7/8-driven innate immune activation with practical tumor-ablation and hydrogel-delivery workflows. This guide explains stock preparation, assay controls, thermal-protection testing, and troubleshooting for translating free-compound experiments into localized chemo-immunomodulation.

• ATRX-Deficient Glioma and RTK Inhibitor Sensitivity

  2026-08-18

  The reference study identifies a genotype-linked vulnerability in high-grade glioma: cells lacking the chromatin remodeler ATRX show increased sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors. Its combination data further suggest that ATRX status may help interpret RTK inhibitor trials and guide temozolomide-based experimental strategies.

• Azilsartan Medoxomil Monopotassium: Assay Guide

  2026-08-17

  Build reproducible AT1-receptor assays with Azilsartan medoxomil monopotassium (TAK 491), from DMSO stock preparation through washout and signaling readouts. The workflow emphasizes sustained antagonism, concentration control, and translational comparison without confusing clinical evidence with bench-level potency.

• miR-196a, MYC, and EAC Aggressiveness

  2026-08-17

  García-Castillo et al. identify miR-196a as a functional driver of esophageal adenocarcinoma aggressiveness rather than only a progression marker. Their data connect miR-196a to NFKBIA loss, VCP downregulation, c-MYC accumulation, TERT activation, epithelial-to-mesenchymal transition, and increased motility, while tissue analysis supports the relevance of this axis in Barrett’s esophagus.

• XAV-939: From Tankyrase Biology to Translation

  2026-08-16

  XAV-939, also known as NVP-XAV939, offers a mechanistically defined way to interrogate tankyrase-driven control of Wnt/β-catenin and Hippo signaling. This article connects pathway biology with practical assay design and translational strategy across cancer research, fibrotic disease research, and bone biology.

8364 records 4/558 page Previous Next 12345 下5页 Last page